Business Segment Information - Reconciliation (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
|
| Business Segment Reconciliation Information | ||||
| Net sales | $ 211,030 | $ 133,537 | $ 547,211 | $ 364,321 |
| Cost of sales | 31,164 | 28,831 | 98,519 | 80,043 |
| Sales, marketing and distribution | 55,238 | 40,207 | 158,136 | 114,675 |
| Research and development | 30,953 | 26,859 | 92,818 | 75,583 |
| Clinical | 17,142 | 11,213 | 50,723 | 31,380 |
| General and administrative | 75,705 | 42,792 | 181,810 | 122,372 |
| Acquired in-process research and development | 0 | 0 | 1,500 | 0 |
| Significant segment expenses | 210,202 | 149,902 | 583,506 | 424,053 |
| Interest income | 2,493 | 2,552 | 7,203 | 8,202 |
| Interest expense | (1,087) | (1,175) | (3,671) | (3,489) |
| Other income (expense), net | 87 | (1,009) | (1,936) | 1,793 |
| Income tax provision | 303 | 234 | 1,443 | 808 |
| Net income (loss) | $ 2,018 | $ (16,231) | $ (36,142) | $ (54,034) |
| X | ||||||||||
- Definition Acquired in process research and development. No definition available.
|
| X | ||||||||||
- Definition Amount of clinical expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and write off of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. No definition available.
|
| X | ||||||||||
- Definition Represents the amount of total significant segment expenses. No definition available.
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business). No definition available.
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|